FBRX
HEALTHCAREForte Biosciences Inc
$26.52-0.77 (-2.82%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving FBRX Today?
No stock-specific AI insight has been generated for FBRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.20$35.80
$26.52
Fundamentals
Market Cap$543M
P/E Ratio—
EPS$-4.71
Dividend Yield—
Dividend / Share—
ROE-1.2%
Profit Margin—
Debt / Equity—
Trading
Volume109K
Avg Volume (10D)—
Shares Outstanding20.5M
FBRX News
20 articles- Top Midday GainersYahoo Finance·Apr 9, 2026
- Forte Biosciences Announces Pricing of $150 Million Public OfferingYahoo Finance·Apr 9, 2026
- Forte Biosciences Announces Proposed Public OfferingYahoo Finance·Apr 8, 2026
- Forte Biosciences, Inc. Announces 2025 Results and Provides UpdateYahoo Finance·Mar 31, 2026
- Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesYahoo Finance·Mar 17, 2026
- Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should KnowYahoo Finance·Feb 25, 2026
- We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business GrowthYahoo Finance·Feb 18, 2026
- Forte Biosciences, Inc. to Present at Upcoming Investor MeetingsYahoo Finance·Feb 9, 2026
- Chief Financial Officer of Forte Biosciences Picks Up 30% More StockYahoo Finance·Jan 4, 2026
- Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing RulesYahoo Finance·Dec 22, 2025
- Positive week for Forte Biosciences, Inc. (NASDAQ:FBRX) institutional investors who lost 1.7% over the past yearYahoo Finance·Dec 12, 2025
- Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides UpdateYahoo Finance·Nov 14, 2025
- Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease SymposiumYahoo Finance·Sep 15, 2025
- We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash WiselyYahoo Finance·Sep 11, 2025
- This Forte Biosciences Insider Increased Their Holding By 273% Last YearYahoo Finance·Aug 15, 2025
- Forte Biosciences, Inc. Announces Results and Provides UpdateYahoo Finance·Aug 14, 2025
- individual investors who own 54% along with institutions invested in Forte Biosciences, Inc. (NASDAQ:FBRX) saw increase in their holdings value last weekYahoo Finance·Jul 5, 2025
- Top Midday DeclinersYahoo Finance·Jun 25, 2025
- Forte Biosciences Announces Pricing of $75 Million Public OfferingYahoo Finance·Jun 25, 2025
- Forte Biosciences announces data from trial in celiac disease for FB102Yahoo Finance·Jun 24, 2025
All 20 articles loaded
Price Data
Open$28.70
Previous Close$27.29
Day High$29.15
Day Low$26.92
52 Week High$35.80
52 Week Low$6.20
52-Week Range
$6.20$35.80
$26.52
Fundamentals
Market Cap$543M
P/E Ratio—
EPS$-4.71
Dividend Yield—
Dividend / Share—
ROE-1.2%
Profit Margin—
Debt / Equity—
Trading
Volume109K
Avg Volume (10D)—
Shares Outstanding20.5M
About Forte Biosciences Inc
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—